Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls (Q52000613)

19 April 2018

title

Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls (English)

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(97)00041-3

10 November 2024

0 references

G. N. Gurguis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9247979

10 November 2024

B. J. Vitton

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9247979

10 November 2024

T. W. Uhde

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9247979

10 November 2024

language of work or name

English

0 references

publication date

1 June 1997

1 reference

19 April 2018

16 June 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9247979

full work available at URL

10 November 2024

https://api.elsevier.com/content/article/PII:S0165178197000413?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(97)00041-3

https://api.elsevier.com/content/article/PII:S0165178197000413?httpAccept=text/plain

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(97)00041-3

10 November 2024

1 reference

19 April 2018

volume

1 reference

19 April 2018

issue

1 reference

19 April 2018

page(s)

27-39

1 reference

19 April 2018

Radioimmunoassay of Plasma 17-Hydroxypregnenolone

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Cardiovascular effects of yohimbine in anaesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Stress Hormones: Their Interaction and Regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

The physiological and pharmacological role of presynaptic alpha- and beta-adrenoceptors in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Endocrine and physiological changes during "spontaneous" panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Assessment of α2 adrenergic autoreceptor function in humans: Effects of oral yohimbine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Agonist-Promoted High Affinity State of the β-Adrenergic Receptor in Human Neutrophils: Modulation by Corticosteroids*

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

The alpha adrenoceptor antagonist properties of idazoxan in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Beta-adrenoceptor desensitization in guinea-pig isolated trachea

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

The release of catecholamines from the adrenal medulla and its modulation by alpha 2-adrenoceptors in the anaesthetized dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Ambulatory monitoring of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Neurotransmitters involved in ACTH secretion: catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Pharmacological evidence for inhibition of ACTH secretion by a central adrenergic system in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Characteristics of the alpha-adrenergic stimulation of adrenocorticotropin secretion in rat anterior pituitary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Influence of yohimbine on release of anterior pituitary hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Evidence for the existence of vascular alpha 2-adrenergic receptors in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Hypothalamic-pituitary-adrenocortical activity in panic disorder: Relationship to plasma catecholamine metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Autonomic and psychic effects of yohimbine hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

EFFECTS OF BENZQUINAMIDE, IN COMPARISON WITH CHLORDIAZEPOXIDE AND PLACEBO, ON SUBJECTIVE EXPERIENCES AND AUTONOMIC PHENOMENA IN STRESS EXPERIMENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Glucocorticoid modulation of beta-adrenergic receptors of cultured rat arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Pharmacological characterisation of the ?-adrenoceptors responsible for a decrease of blood pressure in the nucleus tractus solitarii of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Presence of Postsynaptic α2-Adrenoreceptors of Predominantly Extrasynaptic Location in the Vascular Smooth Muscle of the Dog Hind Limb

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Chromatographic approaches to signal and selectivity enhancement for determination of biogenic amines by liquid chromatography with amperometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Increase of corticotropin-releasing factor staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Effects of Yohimbine on Human Sympathetic Nervous System Function*

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Adrenergic function in patients with panic anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Endocrine and cardiovascular responses during phobic anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Glucocorticoid induction of beta-adrenergic receptors in the DDT1 MF-2 smooth muscle cell line involves synthesis of new receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Plasma catecholamines at rest and exercise in subjects with high- and low-trait anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Activation of beta 2-adrenergic receptors on mouse anterior pituitary tumor cells increases cyclic adenosine 3':5'-monophosphate synthesis and adrenocorticotropin release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Central epinergic inhibition of corticosterone release in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Liquid chromatographic assay for CSF catecholamines using electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Cardiac rate and rhythm in panic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Anxiety in patients with pheochromocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders. Comparison of patients with panic disorder and social phobia and normal control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Fear and anxiety: relationship to noradrenergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Central and Peripheral α-Adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Epinephrine and norepinephrine responses in continuously collected human plasma to a series of stressors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Contrasting patterns of autonomic dysfunction in patients with mitral valve prolapse and panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Situational panic attacks. Behavioral, physiologic, and biochemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Heart rate and blood pressure changes during postural change and isometric handgrip exercise in patients with panic disorder and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Catecholamine secretion as a function of perceived coping self-efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900041-3

7 January 2021

Neurotransmitters and pituitary function: regulation of ACTH secretion

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(97)00041-3

Plasma biogenic amine levels in agoraphobia with panic attacks

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(97)00041-3

Substances modulating the secretion of ACTH by cultured anterior pituitary cells

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(97)00041-3

10 November 2024

Identifiers

1 reference

19 April 2018

1 reference

19 April 2018